Paving the way to better diagnosis and treatment for Langerhans cell histiocytosis
The findings create possibilities for risk-stratification regimens that can be better tailored to individual patients.
Read MoreThe findings create possibilities for risk-stratification regimens that can be better tailored to individual patients.
Read MoreA novel combination therapy resulted in a significant decrease of disease burden in an animal model of LCH.
Read MoreThe 2019 Michael E. DeBakey M.D. Award for Research Excellence ceremony honored five Baylor College of Medicine faculty members for their excellence in published scientific
Read More